TP53 and cancer: Among the five cell lines with wild-type TP53, TOV21G cells were much more responsive to the cytostatic/cytocidal effects of 4SP65 with significantly lower dose-response metrics compared to other TP53 wild-type cancer cell lines (P-values of 0.035 for GI50s to 0.001 for LC99s).